<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>w82505exv99w2.htm
<DESCRIPTION>ASSET PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="right"><FONT size="2"><B>Exhibit&nbsp;99.2</B>
</FONT>


<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">






<P align="center"><FONT size="2">ASSET PURCHASE AGREEMENT
</FONT>
<P align="center"><FONT size="2">by and between
</FONT>
<P align="center"><FONT size="2">Celgene Corporation
</FONT>
<P align="center"><FONT size="2">as Purchaser
</FONT>
<P align="center"><FONT size="2">and
</FONT>
<P align="center"><FONT size="2">EntreMed, Inc.
</FONT>
<P align="center"><FONT size="2">as Seller<p>&nbsp;
</FONT>
<P align="center"><FONT size="2">Dated as of December&nbsp;31, 2002
</FONT>
<P>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">




<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>







<P align="center"><FONT size="2">TABLE OF CONTENTS
</FONT>
<P align="center"><FONT size="2">ARTICLE I CERTAIN DEFINITIONS
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;1.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Certain Definitions</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">1</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;1.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Interpretation</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">5</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE II SALE AND PURCHASE OF ASSETS
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Transfer of Assets</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">5</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Assumed Liabilities</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">7</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Purchase Price</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">7</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Closing</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">7</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Nonassignable Assets</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">8</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;2.6</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Opinion of Counsel</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">8</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE III REPRESENTATIONS AND WARRANTIES OF SELLER
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Organization</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">8</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Authority</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">9</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>No Conflict; Required Filings and Consents</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">9</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Permits; Compliance With Law</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">9</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Absence of Certain Changes or Events</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">10</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.6</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Title to Assets; Sufficiency of Assets</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">11</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.7</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Assumed Contracts</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">11</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.8</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Conveyed Intellectual Property</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">11</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.9</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Litigation</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">12</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.10</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Brokers</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">12</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.11</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Preclinical Testing and Clinical Trials</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">13</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;3.12</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Certain Regulatory Matters</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">13</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;3.13</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Taxes</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">14</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PURCHASER
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;4.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Organization</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">14</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;4.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Authority</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">15</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;4.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>No Conflict; Required Filings and Consents</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">15</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;4.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Litigation</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">15</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;4.5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Brokers</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">16</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE V COVENANTS
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Conduct of the Business</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">16</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">i</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Access to Information; Confidentiality;
Cooperation</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">17</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Appropriate Action; Consents; Filings</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">18</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Further Assurances</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">19</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Tax Matters</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">19</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.6</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Publicity</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">20</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.7</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Certain Provisions Relating to the Transfer</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">20</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.8</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Supplemental Disclosure</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">20</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.9</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Closing Documents</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">20</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.10</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Patent Prosecution</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">21</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.11</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Non-Competition</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">21</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;5.12</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Confidentiality</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">22</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;5.13</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Rights to Certain Technologies of Seller</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">23</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE VI CONDITIONS
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;6.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Conditions to Each Party&#146;s Obligations</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">23</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;6.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Conditions to Obligations of Purchaser</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">23</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;6.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Conditions to Obligations of Seller</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">24</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE VII TERMINATION AND AMENDMENT
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;7.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Termination</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">24</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;7.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Effect of Termination</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">25</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;7.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Amendment</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">25</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;7.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Extension; Waiver</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">25</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE VIII SURVIVAL; INDEMNIFICATION
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;8.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Survival Period</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">26</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;8.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Indemnification</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">26</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;8.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Indemnification Procedures</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">27</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;8.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Qualifications on Liability</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">28</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ARTICLE IX MISCELLANEOUS
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Notices</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">28</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Descriptive Headings</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">29</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Counterparts; Facsimile Signatures</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">29</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Entire Agreement</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">30</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Fees and Expenses</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">30</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.6</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Governing Law</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">30</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.7</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>WAIVER OF JURY TRIAL</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">30</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;9.8</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Assignment</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">30</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">ii</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.9</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Parties in Interest</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">31</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.10</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Interpretation</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">31</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.11</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Severability</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">31</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Section&nbsp;9.12</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Payments</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">31</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top" nowrap><FONT size="2">Section&nbsp;9.13</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>Bulk Sales Laws</U>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">31</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">iii</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS ASSET PURCHASE AGREEMENT (this &#147;<U>Agreement</U>&#148;) is made as of the
31st day of December, 2002, by and between Celgene Corporation, a Delaware
corporation (&#147;<U>Purchaser</U>&#148;), and EntreMed, Inc., a Delaware corporation
(&#147;<U>Seller</U>&#148;).
</FONT>
<P align="center"><FONT size="2"><U>W I T N E S S E T H</U>:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Seller is engaged in the Business;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Purchaser has agreed to acquire from Seller, and Seller has
agreed to sell to Purchaser, the Conveyed Assets on the terms and subject to
the conditions set forth herein; and
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Purchaser has agreed to assume the Assumed Liabilities on the
terms and subject to the conditions set forth herein.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the premises, covenants,
representations and warranties contained herein, and other good and valuable
consideration, the adequacy and receipt of which are hereby acknowledged, the
parties hereto, intending to be legally bound, agree as follows:
</FONT>
<P align="center"><FONT size="2">ARTICLE I
</FONT>
<P align="center"><FONT size="2">CERTAIN DEFINITIONS
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain Definitions</U>. As used in this Agreement,
the following terms shall have the following meanings:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Affiliate&#148; of a specified Person shall mean another Person that directly
or indirectly, through one or more intermediaries, controls, is controlled by,
or is under common control with, such first Person.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Analog Patents&#148; has the meaning ascribed thereto in the Exclusive License
Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Assignment of Intellectual Property&#148; shall mean the instrument evidencing
the assignment to Purchaser of all of Seller&#146;s and its Subsidiaries&#146; right,
title and interest in and to the Conveyed Intellectual Property, which shall be
in form and substance reasonably satisfactory to Purchaser and Seller.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Bill of Sale&#148; shall mean the bill of sale transferring to Purchaser all
of Seller&#146;s and its Subsidiaries&#146; right, title and interest in and to the
Conveyed Assets, which shall be in form and substance reasonably satisfactory
to Purchaser and Seller.
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Business&#148; shall mean the business of researching and developing
pharmaceutical drug products, medical devices, diagnostic products, veterinary
products, vaccines, prophylactics and other commercial products that contain
Thalidomide Analogs as an active ingredient, including, without limitation,
Thalidomide Analogs of a type contemplated by the Analog Patents.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Business Day&#148; shall mean any day on which banks are not required or
authorized to close in New York, New York.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Code&#148; shall mean the Internal Revenue Code of 1986, as amended.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;control&#148; (including the terms &#147;controlled by&#148; and &#147;under common control
with&#148;) shall mean, with respect to a Person, the possession, directly or
indirectly, of the power to direct or cause the direction of the management or
policies of such Person, whether through the ownership of securities or as
trustee or executor, by contract or credit arrangement or otherwise.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Exclusive License Agreement&#148; shall mean the Exclusive License Agreement
among Purchaser, Children&#146;s Medical Center Corporation and, for purposes of
certain provisions thereof, Seller, in the form attached as Exhibit&nbsp;1 to the
Settlement Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;GAAP&#148; shall mean United States generally accepted accounting principles
consistently applied.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Governmental Entity&#148; shall mean a domestic or foreign court, legislature,
governmental agency, governmental commission, or a judicial or regulatory
authority of any government.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Instrument of Assignment and Assumption&#148; shall mean the instrument
evidencing Seller&#146;s and its Subsidiaries&#146; assignment to Purchaser of the
Assumed Liabilities, which shall be in form and substance reasonably
satisfactory to Purchaser and Seller.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Intellectual Property&#148; shall mean statutory and common law trademarks,
service marks, trade names, Internet domain names, designs, trade dress, logos,
slogans and general intangibles of like nature, together with registrations and
applications relating to any of the foregoing; patents and copyrights, together
with registrations and applications relating to any of the foregoing; Software;
confidential information, data, compilations, technology, Know-How and goodwill
relating to any of the foregoing, and all rights to sue and recover damages or
obtain injunctive relief for past and future infringement, misappropriation,
violation, dilution or breach of any of the foregoing.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;IRS&#148; shall mean the Internal Revenue Service.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Know-How&#148; shall mean any information, in any form whatsoever, relating to
Thalidomide Analogs, whether such information is patentable or not, including
without limitation technical and non-technical information, marketing, cost,
and sales
</FONT>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">information, know-how, skill, knowledge, experience, machinery, equipment
and equipment designs, inventions, invention disclosure statements, notebooks,
practices, methods, processes, procedures, manufacturing technology,
compositions, reagents, devices, formulae, chemical structures and models,
formulations, protocols, methodologies, techniques, algorithms, designs,
drawings, plans, diagrams, specifications, models, samples, materials
(including without limitation chemical and biological materials), data
(including without limitation pharmacological, toxicological and clinical test
data, analytical and quality assurance and quality control data), assays, and
the results (including without limitation of experimentation, tests and
assays), to the extent such information relates to or is used, useful, or
potentially useful in, the conduct of the Business, expressly including,
without limitation, the items set forth in Section&nbsp;1.1 of the Seller Disclosure
Letter.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;knowledge&#148; of any Person that is not an individual shall mean, with
respect to any specific matter, the knowledge, after reasonable inquiry, of
such Person&#146;s executive officers and any other officer having responsibility
for such matter.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Law&#148; shall mean any foreign or domestic law, including the common law,
statute, code, rule, regulation, ordinance, order, judgment, writ, injunction
or decree.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Lien&#148; shall mean any lien, security interest, pledge, mortgage, claim,
charge, hypothecation or other encumbrance of any nature whatsoever.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Litigations&#148; has the meaning ascribed thereto in the Settlement
Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Material Adverse Effect&#148; shall mean any fact, event, circumstance or
condition (excluding general economic conditions) that has a material adverse
effect, individually or in the aggregate, on the financial condition, results
of operations, assets, liabilities or prospects of the Business or the ability
of Seller to perform any of its material obligations under, or to consummate
the transactions contemplated by, this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Permitted Liens&#148; shall mean: (i)&nbsp;Liens for Taxes or assessments which
are not yet due and payable or are being contested in good faith by appropriate
proceedings; (ii)&nbsp;mechanics&#146;, warehousemens&#146;, materialmens&#146;, contractors&#146;,
workmens&#146;, repairmens&#146;, carriers&#146; and other similar Liens; and (iii)&nbsp;Liens
incurred in the ordinary course of business in connection with workers&#146;
compensation, unemployment insurance and other types of social security.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Person&#148; shall mean any individual, group, corporation, partnership or
other organization or entity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Prosecution&#148; has the meaning ascribed thereto in the Exclusive License
Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Regulatory Filings&#148; shall mean any and all applications made to the
United States Food and Drug Administration or any other analogous United States
or
</FONT>
<P align="center"><FONT size="2">3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">foreign regulatory agency or authority, seeking approval to investigate,
market, or sell any Thalidomide Analog, including without limitation all
Investigational New Drug Applications, New Drug Applications, Abbreviated New
Drug Applications and Orphan Drug Status applications, and all grants of any
such applications, and of any other rights to investigate, market or sell any
Thalidomide Analog, and all extensions of all such grants and rights.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Related Instruments&#148; shall mean the Bill of Sale, the Instrument of
Assignment and Assumption, the Assignment of Intellectual Property, the
Exclusive License Agreement, the Securities Purchase Agreement and the
Settlement Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Securities Purchase Agreement&#148; shall mean the Securities Purchase
Agreement between Purchaser and Seller in the form of <U>Exhibit&nbsp;A</U> hereto,
together with all exhibits thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Seller Disclosure Letter&#148; shall mean the disclosure letter delivered by
Seller to Purchaser in connection with the execution of this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Settlement Agreement&#148; shall mean the Settlement and Mutual Release
Agreement between Purchaser and Seller in the form of <U>Exhibit&nbsp;B</U> hereto,
and all Exhibits thereto, including without limitation the Exclusive License
Agreement among Purchaser, Children&#146;s Medical Center Corporation, and, for
purposes of certain provisions thereof, Seller, attached thereto as Exhibit&nbsp;1,
and the Stipulations of Dismissal executed on behalf of both Seller and
Purchaser, attached thereto as Exhibits 2 and 3.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Software&#148; shall mean computer programs, including any and all software
implementations of algorithms, models and methodologies whether in source code
or object code form, databases and compilations, including any and all data and
collections of data, all documentation, including user manuals and training
materials, related to any of the foregoing and the content and information
contained on any Web site.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Subsidiary&#148; of any Person means any corporation, partnership, joint
venture or other legal entity of which such Person owns, directly or
indirectly, a majority of the stock or other equity interests the holders of
which are generally entitled to vote for the election of the Board of Directors
or other governing body of such corporation or other legal entity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Tax Return&#148; shall mean any report, declaration, statement, return or
other information filed in respect of Taxes, and any claims for refund of
Taxes, including any amendments or supplements to any of the foregoing with any
taxing authority with respect to Taxes imposed upon or attributable to the
operations of the Business.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Taxes&#148; shall mean any and all taxes, levies or other like assessments,
including, but not limited to, income, transfer, gains, gross receipts, excise,
inventory, property (real, personal or intangible), custom, duty, sales, use,
license, withholding, payroll, employment, capital stock and franchise taxes
(including any fee, assessment or other charge in the nature of or in lieu of
any tax), imposed by the United States, or any state, local or foreign
government or subdivision or agency thereof, any interest,
</FONT>
<P align="center"><FONT size="2">4</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">penalties, additions to tax or additional amounts in respect of any of the
foregoing (whether disputed or not), any transferee or secondary liability in
respect of tax (whether imposed by Law, contractual agreement or otherwise) and
any liability in respect of any tax as a result of being a member of any
affiliated, consolidated, combined, unitary or similar group.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Thalidomide Analogs&#148; has the meaning ascribed thereto in the Exclusive
License Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Transaction Taxes&#148; shall mean any and all sales, use, transfer, filing,
conveyance, recording, gross receipts, value added and similar taxes imposed by
the United States, or any state, local or foreign government or subdivision or
agency thereof, any interest, penalties, additions to tax or additional amounts
in respect of any of the foregoing (whether disputed or not), and any
transferee or secondary liability in respect of any of the foregoing (whether
imposed by Law, contractual agreement or otherwise).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretation</U>. Unless otherwise indicated to the
contrary in this Agreement by the context or use thereof: (a)&nbsp;the words,
&#147;herein,&#148; &#147;hereto,&#148; &#147;hereof&#148; and words of similar import refer to this
Agreement as a whole and not to any particular Section or paragraph hereof; (b)
words importing the masculine gender shall also include the feminine and
neutral genders, and vice versa; (c)&nbsp;words importing the singular shall also
include the plural, and vice versa; and (d)&nbsp;the word &#147;including&#148; means
&#147;including without limitation.&#148;
</FONT>
<P align="center"><FONT size="2">ARTICLE II
</FONT>
<P align="center"><FONT size="2">SALE AND PURCHASE OF ASSETS
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer of Assets</U>. (a)&nbsp;On the terms and subject to
the conditions set forth in this Agreement, at the Closing, Seller shall sell,
assign, convey, transfer and deliver (and Seller shall cause its Subsidiaries
to sell, assign, convey, transfer and deliver) to Purchaser, and Purchaser
shall purchase, all assets, properties and rights owned by Seller or any of its
Subsidiaries, or to which any of them is entitled, belonging to, used or
intended to be used in the Business, of every kind and description and wherever
located, free and clear of all Liens (except for Permitted Liens), including,
without limitation, all of Seller&#146;s and its Subsidiaries&#146; rights, title and
interest in and to the assets set forth below, but excluding the Excluded
Assets (collectively, the &#147;<U>Conveyed Assets</U>&#148;):
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all Intellectual Property relating to the Business,
including the Intellectual Property set forth in Section&nbsp;2.1(a)(i)
of the Seller Disclosure Letter (the &#147;<U>Conveyed Intellectual
Property</U>&#148;), all tangible embodiments of all such Conveyed
Intellectual Property and true and complete files relating to the
Prosecution, assertion, enforcement or defense of any of the
Conveyed Intellectual Property;</FONT></TD>
</TR>

</TABLE>
<P align="center"><FONT size="2">5</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>





<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all rights and interest as of the Closing in and to the
contracts, agreements, arrangements, commitments and
understandings (collectively, &#147;<U>Contracts</U>&#148;) relating to the
Business and listed on Section&nbsp;2.1(a)(ii) of the Seller Disclosure
Letter, which schedule shall include all applicable patent
licenses and consulting agreements regarding FDA and patent
matters (the &#147;<U>Assumed Contracts</U>&#148;);</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;all pre-clinical and clinical data and market research
data used in connection with the Business, all web site content
and all records, including supplier lists, manufacturing records,
sampling records, product samples, standard operating procedures
and batch records relating to the Business;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;all Permits and applications for Permits, but only to
the extent Seller is permitted to transfer such Permits and
applications;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All books, records, files and papers, whether in hard
copy or computer format, to the extent they contain information
relating to the Business, including, without limitation, all
financial records, correspondence and other documents and all
notices to or from, and filings and other communications with, the
FDA, the U.S. Patent and Trademark Office and other patent
offices;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All claims, causes of action, rights of recovery and
rights of set-off of any kind pertaining solely to, or arising
solely out of, the Business;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;&nbsp;&nbsp;&nbsp;All Regulatory Filings; and</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;&nbsp;&nbsp;The goodwill of the Business together with the right
of Purchaser to represent itself to third parties as the
successor-in-interest to the Business.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in this Agreement,
the term &#147;Conveyed Assets&#148; shall not include: (i)&nbsp;any cash, cash equivalents,
bank deposits or similar cash items of Seller as of the Closing Date; (ii)
rights under the Assumed Contracts relating to the performance or
non-performance of such Assumed Contracts prior to the Closing; (iii)&nbsp;all
rights of Seller under this Agreement and the Related Instruments; (iv)&nbsp;any
interests in any real estate; (v)&nbsp;any rights to refunds, rebates or abatements
of any Taxes with respect to the Conveyed Assets or the Business that relate to
any period ending on or prior to the Closing Date; (vi)&nbsp;any insurance policies
of Seller or its Affiliates or rights thereunder or proceeds thereof; and (vii)
assets under any employee benefit plan of Seller or any of its Subsidiaries
(the rights, properties and assets expressly excluded from &#147;Conveyed Assets&#148; by
this Section&nbsp;2.1(b) are referred to collectively as the &#147;<U>Excluded
Assets</U>&#148;).
</FONT>
<P align="center"><FONT size="2">6</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assumed Liabilities</U>. (a)&nbsp;In partial consideration of the sale of the Conveyed Assets to
Purchaser, at the Closing, Purchaser shall assume only the following
liabilities and obligations of Seller and its Subsidiaries to the extent
related to the Business or the Conveyed Assets, in each case only to the extent
arising and relating solely to the period after the Closing (collectively, the
&#147;<U>Assumed Liabilities</U>&#148;):
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all liabilities and obligations under the Assumed
Contracts;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all liabilities and obligations specifically assumed by
Purchaser pursuant to other provisions of this Agreement;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all liabilities and obligations with respect to the
Permits to the extent such Permits are Conveyed Assets.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as otherwise provided in Section&nbsp;2.2(a), Seller and its
Subsidiaries shall retain all, and Purchaser shall not assume, pay, perform,
defend or discharge any, liabilities and obligations of Seller and its
Subsidiaries of any and every kind whatsoever, whether disclosed, undisclosed,
direct, indirect, absolute, contingent, secured, unsecured, accrued, known,
unknown or otherwise (collectively, the &#147;<U>Excluded Liabilities</U>&#148;).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase Price</U>. In consideration for the sale of the
Conveyed Assets and the Settlement Agreement, at the Closing Purchaser shall
(i)&nbsp;assume the Assumed Liabilities and (ii)&nbsp;pay to Seller a purchase price
equal to $10,000,000 (the &#147;<U>Purchase Price</U>&#148;). The Purchase Price shall
be payable in cash by wire transfer of immediately available funds to an
account designated in writing by Seller at least two Business Days prior to the
Closing Date.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>. (a)&nbsp;The consummation of the transactions
contemplated by this Agreement (the &#147;<U>Closing</U>&#148;) will take place on the
second Business Day following the satisfaction or waiver of the conditions set
forth in Article&nbsp;VI hereof (other than those conditions which, by their nature,
can only be satisfied at Closing), at 10:00&nbsp;a.m. (New York City time), at the
offices of Proskauer Rose LLP, 1585 Broadway, New York, New York 10036, or at
such other time and place as shall be mutually agreed upon by the parties. The
date on which the Closing occurs is referred to herein as the &#147;<U>Closing
Date</U>.&#148;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, Seller shall deliver or cause to be delivered to
Purchaser the following: (i)&nbsp;a duly executed Bill of Sale; (ii)&nbsp;a duly
executed Instrument of Assignment and Assumption; (iii)&nbsp;a duly executed
Assignment of Intellectual Property; (iv)&nbsp;the Exclusive License Agreement duly
executed by Seller and Children&#146;s Medical Center Corporation; (v)&nbsp;a duly
executed Securities Purchase Agreement; (vi)&nbsp;a duly executed Settlement
Agreement, together with duly executed originals of the Stipulations of
Dismissal attached thereto as Exhibits 2 and 3; (vii)&nbsp;an opinion of counsel to Seller, in form and substance reasonably
satisfactory to Purchaser; (viii)&nbsp;consents, approvals, authorizations, waivers
and Permits of all Persons and
</FONT>
<P align="center"><FONT size="2">7</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><FONT size="2">Governmental Entities necessary for Purchaser to
operate the Business and use the Conveyed Assets substantially as heretofore
operated and used; (ix)&nbsp;evidence of the release of all Liens on the Conveyed
Assets, in form and substance reasonably satisfactory to Purchaser; and (x)
such other documents as may be reasonably requested by Purchaser to vest in
Purchaser good and marketable to the Conveyed Assets.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, Purchaser shall deliver or cause to be delivered to
Seller the following: (i)&nbsp;cash in the amount of the Purchase Price by wire
transfer of immediately available funds; (ii)&nbsp;a duly executed Instrument of
Assignment and Assumption; (iii)&nbsp;a duly executed Exclusive License Agreement;
(iv)&nbsp;a duly executed Securities Purchase Agreement; and (v)&nbsp;a duly executed
Settlement Agreement, together with duly executed originals of the Stipulations
of Dismissal attached thereto as Exhibits 2 and 3.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonassignable Assets</U>.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement, nor the consummation of the transactions
contemplated hereby, shall be construed as an attempt or agreement to assign or
transfer any Conveyed Asset (including any Assumed Contract) to Purchaser which
by its terms or by Law is nonassignable without the consent of a third party or
a Governmental Entity (a &#147;<U>Nonassignable Asset</U>&#148;), unless and until such
consent shall have been obtained. From and after the Closing, Seller shall use
reasonable best efforts and shall cooperate with Purchaser to the extent
requested by Purchaser to obtain any such necessary consents and, to the extent
that such consents are not obtained, use reasonable best efforts to assure
Purchaser of the benefits of such Conveyed Assets under reasonable and lawful
arrangements. Notwithstanding anything to the contrary contained in this
Agreement, to the extent that such consents are not obtained, or the benefits
of such Conveyed Assets are not provided to Purchaser, Purchaser shall have no
obligations with respect thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel</U>. Contemporaneously with the
execution and delivery of this Agreement, Arnold &#038; Porter, counsel to Seller,
is delivering its opinion addressed to Purchaser with respect to the matters
set forth in Sections&nbsp;3.1 and 3.2 hereof.
</FONT>
<P align="center"><FONT size="2">ARTICLE III
</FONT>
<P align="center"><FONT size="2">REPRESENTATIONS AND WARRANTIES OF SELLER
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller represents and warrants to Purchaser as follows (reference to
Seller in this Article&nbsp;III shall include its Subsidiaries, unless the context
otherwise requires):
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization</U>. Seller is a corporation duly organized,
validly existing and in good standing under the Laws of the State of Delaware.
Seller has the requisite power and authority to own, lease and operate the Conveyed Assets and to conduct the
Business as it is now being conducted.
</FONT>
<P align="center"><FONT size="2">8</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority</U>. Seller has the requisite power and
authority to execute and deliver this Agreement and the Related Instruments, to
perform its obligations hereunder and thereunder and to consummate the
transactions contemplated hereby and thereby. The execution and delivery by
Seller of this Agreement and the Related Instruments, the performance by Seller
of its obligations hereunder and thereunder and the consummation of the
transactions contemplated hereby and thereby have been authorized by all
requisite corporate action on the part of Seller and no other authorization of
Seller or its shareholders is required to authorize the execution and delivery
by Seller of this Agreement or the Related Instruments, the performance by
Seller of its obligations hereunder and thereunder or the consummation of the
transactions contemplated hereby or thereby. This Agreement has been validly
executed and delivered by Seller and constitutes, and each Related Instrument
that is to be executed and delivered by Seller will constitute when executed
and delivered by Seller, a legal, valid and binding obligation of Seller
enforceable against Seller in accordance with its terms.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflict; Required Filings and Consents</U>. (a)
Except as set forth in Section&nbsp;3.3(a) of the Seller Disclosure Letter, the
execution and delivery by Seller of this Agreement and the Related Instruments
do not, and the performance by Seller of its obligations under this Agreement
and the Related Instruments will not, (i)&nbsp;conflict with or violate any
provision of Seller&#146;s certificate of incorporation or Seller&#146;s bylaws, (ii)
assuming that all consents, approvals, authorizations and permits described in
Section&nbsp;3.3(b) have been obtained and that all filings and notifications
described in Section&nbsp;3.3(b) have been made and any waiting periods thereunder
have terminated or expired, conflict with or violate any Law applicable to
Seller or by which any of the Conveyed Assets is bound, or (iii)&nbsp;assuming that
all consents, approvals, authorizations and permits described in Section&nbsp;3.3(b)
have been obtained and that all filings and notifications described in Section
3.3(b) have been made and any waiting periods thereunder have terminated or
expired, require any consent or approval under, result in any breach of or any
loss of any benefit under, constitute a change of control or default (or an
event which with notice or lapse of time or both would become a default) under,
or give to others any right of termination, acceleration or cancellation of,
any Assumed Contract or result in the creation of a Lien on any Conveyed Asset.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by Seller of this Agreement and the Related
Instruments do not, and the performance by Seller of its obligations under this
Agreement and the Related Instruments will not, require any consent, approval,
authorization or permit of, or filing with or notification to, any Governmental
Entity, except (i)&nbsp;as set forth in Section&nbsp;3.3(b) of the Seller Disclosure
Letter and (ii)&nbsp;where failure to obtain such consents, approvals,
authorizations or permits, or to make such filings or notifications, would not,
individually or in the aggregate, reasonably be expected to prevent or materially delay the performance or consummation of
this Agreement or the Related Instruments by Seller.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Permits; Compliance With Law</U>. (a)&nbsp;Seller is in
possession of all authorizations, licenses, permits, registrations,
certificates, approvals
</FONT>
<P align="center"><FONT size="2">9</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">and clearances of Governmental Entities (including
under the Federal Food, Drug and Cosmetic Act of 1938, as amended (the
&#147;<U>FDCA</U>&#148;), and the regulations of the United States Food and Drug
Administration (the &#147;<U>FDA</U>&#148;) promulgated thereunder) necessary to own,
lease and operate the Conveyed Assets and to carry on the Business as it is
being conducted as of the date hereof (the &#147;<U>Permits</U>&#148;), and all such
Permits are valid and in full force and effect.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller&#146;s conduct of the Business has not and does not conflict with or
violate in any material respect (i)&nbsp;any Law applicable to the Business or by
which any Conveyed Asset is bound or affected or (ii)&nbsp;any Permits. There are
no outstanding notices of violations, demands, claims, orders, judgments,
writs, injunctions or decrees of any Governmental Entity or any third party
that apply to the Conveyed Assets or the Business that restrict the ownership,
disposition or use of the Conveyed Assets or the conduct of the Business in any
material respect or that otherwise seek to impose liability or obligations on
Seller under applicable Law.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain Changes or Events</U>. Except as set
forth in Section&nbsp;3.5 of the Seller Disclosure Letter, since December&nbsp;31, 2001,
except as expressly contemplated by this Agreement, with regard to the Conveyed
Assets, Seller has not suffered a Material Adverse Effect with respect to the
Business and has conducted the Business in the ordinary course and Seller has
not, with respect to the Business:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;subjected any of the Conveyed Assets to any Liens, other than
Permitted Liens;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sold, assigned, transferred, leased, subleased, licensed, sublicensed
or otherwise disposed of, to any third party, any properties or assets
necessary for the conduct of, or used in, the Business, other than in the
ordinary course of business;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;entered into, terminated or amended any Contract, other than in the
ordinary course of business;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;transferred to any third party any rights under any license,
sublicense or other agreement with respect to any Conveyed Intellectual
Property or any Intellectual Property that is the subject of the Exclusive
License Agreement;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;surrendered, revoked or otherwise terminated any Permit, other than in
the ordinary course of business;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incurred any Assumed Liabilities, other than in the ordinary course of
business;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;waived, released or assigned any rights in connection with the
Business, other than in the ordinary course of business; or
<P align="center"><FONT size="2">10</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;agreed, whether in writing or otherwise, to do any of the foregoing,
except as expressly contemplated by this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Assets; Sufficiency of Assets</U>. (a)&nbsp;Seller
has, and at the Closing Seller will deliver to Purchaser, good, valid and
marketable title to all of the Conveyed Assets free and clear of all Liens,
other than Permitted Liens.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Conveyed Assets and the rights of Purchaser under the Exclusive
License Agreement include all assets and Intellectual Property that are
necessary for the conduct of the Business immediately following the Closing in
substantially the same manner as currently conducted by Seller, except for the
Excluded Assets. None of the Conveyed Assets is used by Seller or any Affiliate
of Seller in connection with any business or enterprise other than the
Business.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assumed Contracts</U>. True and complete copies of all
Assumed Contracts have been delivered or made available to Purchaser. Each of
the Assumed Contracts is valid and binding on Seller and the other parties
thereto and is in full force and effect, and, upon consummation of the
transactions contemplated by this Agreement, except to the extent that any
consents set forth in Section&nbsp;3.3(a) of the Seller Disclosure Letter are not
obtained, shall continue in full force and effect without penalty or other
adverse consequences. Except as set forth in Section&nbsp;3.7 of the Seller
Disclosure Letter, neither Seller nor, to the knowledge of Seller, any other
party thereto is in material default under any Assumed Contract (and no
condition exists that, with notice or lapse of time or both, would become such
a material default by any such party).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conveyed Intellectual Property</U>. Except as set forth in
Section&nbsp;3.8 of the Seller Disclosure Letter:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller owns or has exclusive rights to the Conveyed
Intellectual Property free and clear of all Liens, other than
Permitted Liens;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Conveyed Intellectual Property and the Intellectual
Property that is the subject of the Exclusive License Agreement
have been duly maintained and have not been cancelled, expired or
abandoned;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for the Litigations, Seller has not received
notice from any third party regarding any actual or potential
infringement or misappropriation by Seller of any Intellectual
Property of such third party relating to the Conveyed Assets, the
Business or any Intellectual Property that is the subject of the
Exclusive License Agreement, and Seller has no knowledge of any
reasonable basis for such a claim against Seller. Seller is not
aware of any issued third party patents or other third party
intellectual property rights that would be infringed by the
exercise by Purchaser of any right granted to it under this
Agreement or the Exclusive License Agreement;</FONT></TD>
</TR>

</TABLE>
<P align="center"><FONT size="2">11</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>





<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for the Litigations, Seller has not received
notice from any third party regarding any assertion or claim
challenging the validity of any Conveyed Intellectual Property or
any Intellectual Property that is the subject of the Exclusive
License Agreement and Seller has no knowledge of any reasonable
basis for such a claim;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for the Litigations, to the knowledge of Seller,
no third party is misappropriating, infringing, diluting or
violating any Conveyed Intellectual Property or any Intellectual
Property that is the subject of the Exclusive License Agreement.
Seller has not notified any third party that it may be
misappropriating, infringing, diluting or violating any Conveyed
Intellectual Property or any Intellectual Property that is the
subject of the Exclusive License Agreement;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except for the Litigations, Seller has not received any
notice of interfering subject matter with respect to any Conveyed
Intellectual Property or any Intellectual Property that is the
subject of the Exclusive License Agreement, and is not aware of
any third party patents or patent applications that contain any
interfering subject matter with any of same or any inventorship
challenges raised by a third party relating to any of same;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller has complied with the required duty of candor
and good faith in dealing with the United States Patent and
Trademark Office with respect to the Conveyed Intellectual
Property, including the duty to disclose all information believed
to be material to the patentability of same; and</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the knowledge of Seller, no third party, including
any academic organization or Governmental Entity, possesses rights
to any of the Conveyed Intellectual Property or any Intellectual
Property that is the subject of the Exclusive License Agreement.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section&nbsp;3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Litigation</u>. Except as set forth in Section&nbsp;3.9 of the
Seller Disclosure Letter, there is no material suit, claim, action, proceeding
or investigation pending or, to the knowledge of Seller, threatened against
Seller or any of its licensors (including Children&#146;s Medical Center
Corporation) in respect of the Conveyed Assets or the Business. There is no
suit, claim, action, proceeding or investigation pending or, to the knowledge
of Seller, threatened against Seller that challenges the transactions
contemplated by this Agreement or the Related Instruments and would be
reasonably expected to prevent or materially interfere with or delay the
performance or consummation of the transactions contemplated hereby or thereby.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers</U>. No broker, finder or investment banker
(other than Ferghana Partners Inc., all fees of which shall be paid by Seller
in connection with
</FONT>
<P align="center"><FONT size="2">12</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">the transactions contemplated hereby) is entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the
transactions contemplated by this Agreement based upon arrangements made by or
on behalf of Seller.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Preclinical Testing and Clinical Trials</U>. To Seller&#146;s
knowledge, the human clinical trials, animal studies and other preclinical
tests conducted by Seller or in which Seller has participated, and such studies
and tests conducted on behalf of Seller, with respect to the Business were and,
if still pending, are being conducted in accordance with experimental
protocols, informed consents, procedures and controls generally used by
qualified experts in the preclinical or clinical study of comparable products.
Neither Seller nor any agent or representative of Seller has received any
written notice or correspondence from the FDA or any other Governmental Entity
requiring the termination, suspension or modification (other than such
modifications as are normal in the regulatory process) of any animal studies,
preclinical tests or clinical trials conducted by or on behalf of Seller or in
which Seller has participated with respect to the Business. To Seller&#146;s
knowledge, no clinical investigator acting for Seller with respect to the
Business has been or is now, or is threatened to become, the subject of any
disbarment or disqualification proceedings by any Governmental Entity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Regulatory Matters</U>. With respect to the
Business:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.12(a) of the Seller Disclosure Letter sets forth a complete
and accurate list of all Regulatory Filings and all material written
communications between the Seller, on the one hand, and the FDA or any other
Governmental Entity, on the other hand, and all written summaries of material
discussions between any such parties. Seller has made available to Purchaser
copies of all such documents.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller has filed with the FDA and all applicable state, local and
foreign regulatory bodies for, and received approval of, all Regulatory Filings
and all other registrations, applications, licenses, requests for exemptions,
permits and other regulatory authorizations necessary to conduct the Business
as currently conducted and as currently proposed to be conducted. Seller is
and has been in compliance in all material respects with all such Regulatory
Filings, registrations, applications, licenses, requests for exemptions,
permits and other regulatory authorizations. Seller is and has been in
compliance in all material respects with all FDA, state, local and foreign
rules, regulations, guidelines and policies, including, but not limited to,
FDA, state, local and foreign rules, regulations, guidelines and policies
relating to good manufacturing practice (&#147;GMP&#148;) and good laboratory practice
(&#147;GLP&#148;). Seller has no reason to believe that any party granting any such
Regulatory Filing, registration, application, license, request for exemption,
permit or other regulatory authorization is considering terminating, limiting,
suspending, revoking, canceling, rescinding, refusing to renew in the ordinary
course or modifying the same and knows of no basis for any such action.
</FONT>
<P align="center"><FONT size="2">13</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller is in compliance in all material respects with all obligations
arising under any consent decree, consent agreement, warning letter, Form&nbsp;483
issued by or entered into with the FDA or other notice, response or commitment
made to the FDA or any comparable state, local or foreign Governmental Entity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller has disclosed to Purchaser any warning letters or Form&nbsp;483s or
similar notices, or other correspondence relating to Seller&#146;s compliance status
under applicable legal requirements, from the FDA or any comparable state,
local or foreign Governmental Entity within the last three years.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Seller nor, to Seller&#146;s knowledge, any of its officers,
employees, independent contractors or agents has knowingly committed any act,
made any statement or failed to make any statement that would reasonably be
expected to provide a basis for the FDA to invoke its policy respecting &#147;Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&#148; set
forth in 56 Fed. Reg. 46191 (September&nbsp;10, 1991) and any amendments thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither Seller nor, to Seller&#146;s knowledge, any of its officers,
employees, independent contractors or agents has been convicted of any crime or
engaged in any conduct which could result in debarment under 21 U.S.C. &#167; 335a
or any similar state, local or foreign Law.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are no proceedings pending or, to Seller&#146;s knowledge, threatened
with respect to a violation by Seller of the Food, Drug and Cosmetic Act, FDA
regulations adopted thereunder, the Controlled Substance Act or any other
legislation or regulation promulgated by any other Governmental Entity that
reasonably might be expected to result in criminal liability.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>. Seller has timely filed all material Tax Returns required to be filed with
respect to Taxes pertaining, in whole or in part, to the Conveyed Assets or the
Business. All such Tax Returns are true, correct and complete in all material
respects, and Seller has duly paid all Taxes shown on such Tax Returns and has
paid or made adequate provision for payment of all accrued but unpaid Taxes
anticipated in respect of such Tax Returns. Seller has not received notice
from a taxing authority in a jurisdiction where Seller does not file Tax
Returns that Seller is or may be subject to taxation by such jurisdiction.
There are no Tax Liens upon any of the Conveyed Assets, except Permitted Liens.
</FONT>
<P align="center"><FONT size="2">ARTICLE IV
</FONT>
<P align="center"><FONT size="2">REPRESENTATIONS AND WARRANTIES OF PURCHASER
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser represents and warrants to Seller as follows:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization</U>. Purchaser is a corporation duly
organized, validly existing and in good standing under the Laws of the State of
Delaware.
</FONT>
<P align="center"><FONT size="2">14</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority</U>. Purchaser has the requisite power and
authority to execute and deliver this Agreement and the Related Instruments, to
perform its obligations hereunder and thereunder and to consummate the
transactions contemplated hereby and thereby. The execution and delivery by
Purchaser of this Agreement and the Related Instruments, the performance by
Purchaser of its obligations hereunder and thereunder and the consummation of
the transactions contemplated hereby and thereby have been authorized by all
requisite corporate action on the part of Purchaser and no other authorization
of Purchaser or its shareholders is required to authorize the execution and
delivery by Purchaser of this Agreement or the Related Instruments, the
performance by Purchaser of its obligations hereunder or thereunder or the
consummation of the transactions contemplated hereby or thereby. This
Agreement has been validly executed and delivered by Purchaser and constitutes,
and each Related Instrument that is to be executed and delivered by Purchaser
will constitute when executed and delivered by Purchaser, a legal, valid and
binding obligation of Purchaser, enforceable against Purchaser in accordance
with its terms.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflict; Required Filings and Consents</U>. (a)&nbsp;The
execution and delivery by Purchaser of this Agreement and the Related
Instruments do not, and the performance by Purchaser of its obligations under
this Agreement and the Related Instruments will not, (i)&nbsp;conflict with or
violate any provision of Purchaser&#146;s certificate of incorporation or
Purchaser&#146;s bylaws, (ii)&nbsp;assuming that all consents, approvals, authorizations
and permits described in Section&nbsp;4.3(b) have been obtained and that all filings
and notifications described in Section&nbsp;4.3(b) have been made and any waiting
periods thereunder have terminated or expired, conflict with or violate any Law applicable to Purchaser or by which any material property
or asset of Purchaser is bound or (iii)&nbsp;assuming that all consents, approvals,
authorizations and permits described in Section&nbsp;4.3(b) have been obtained and
that all filings and notifications described in Section&nbsp;4.3(b) have been made
and any waiting periods thereunder have terminated or expired, require any
consent or approval under, result in any breach of, or constitute a default (or
an event which with notice or lapse of time or both would become a default)
under, any material contract to which Purchaser is a party or by which
Purchaser is bound.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by Purchaser of this Agreement and the
Related Instruments do not, and the performance by Purchaser of this Agreement
and the Related Instruments will not, require any consent, approval,
authorization or permit of, or filing with or notification to, any Governmental
Entity, except where failure to obtain such consents, approvals, authorizations
or permits, or to make such filings or notifications, would not, individually
or in the aggregate, reasonably be expected to prevent or materially delay the
performance or consummation of this Agreement or the Related Instruments by
Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. There is no suit, claim, action,
proceeding or investigation pending or, to the knowledge of Purchaser,
threatened against Purchaser that challenges the transactions contemplated by
this Agreement or the Related Instruments and would be reasonably expected to
prevent or materially interfere with or
</FONT>
<P align="center"><FONT size="2">15</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">delay the performance or consummation
of the transactions contemplated hereby or thereby.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers</U>. No broker, finder or investment banker is
entitled to any brokerage, finder&#146;s or other fee or commission in connection
with the transactions contemplated by this Agreement based upon arrangements
made by or on behalf of Purchaser.
</FONT>
<P align="center"><FONT size="2">ARTICLE V
</FONT>
<P align="center"><FONT size="2">COVENANTS
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct of the Business</U>. During the period from the
date hereof to the Closing, except as otherwise expressly provided in this
Agreement, or unless Purchaser shall otherwise consent in writing, Seller
shall, and shall cause its Subsidiaries to, (x)&nbsp;operate the Business in the
ordinary course of business consistent with past practice and (y)&nbsp;use its
reasonable best efforts to preserve substantially intact the Conveyed Assets
and the Business. Without limiting the generality of the foregoing, and except
as otherwise expressly provided in this Agreement, during the period from the
date hereof to the Closing, without the prior written consent of Purchaser,
Seller shall not, and shall cause its Subsidiaries not to:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;subject any of the Conveyed Assets to any Lien, other
than Permitted Liens;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sell, assign, transfer, lease, sublease, license,
sublicense or otherwise dispose of any Conveyed Assets, other than
in the ordinary course of business;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;transfer to any third party any rights, whether under
licenses, sublicenses, other agreements or otherwise, with respect
to any Conveyed Intellectual Property or any Intellectual Property
that is the subject of the Exclusive License Agreement;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter into, terminate or amend any Contract that
constitutes or would constitute an Assumed Contract, except in the
ordinary course of business;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;abandon or terminate any clinical trials relating to the
Business other than in the ordinary course of business (including
for safety concerns) or in accordance with the terms of existing
arrangements with respect to such clinical trials;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;surrender, revoke or otherwise terminate any Permit,
other than in the ordinary course of business;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;incur any Assumed Liabilities, other than in the
ordinary course of business;</FONT></TD>
</TR>

</TABLE>
<P align="center"><FONT size="2">16</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>





<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;waive, release or assign any rights in connection with
the Business, other than in the ordinary course of business; or</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;agree, whether in writing or otherwise, to do any of the
foregoing.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Access to Information; Confidentiality; Cooperation</U>.
(a)&nbsp;After the date hereof and prior to the Closing, Seller shall permit
Purchaser and its authorized representatives to have reasonable access during
normal business hours, upon reasonable prior notice to Seller, to Seller&#146;s
properties, books, records, contracts, commitments and personnel relating to
the Conveyed Assets, the Assumed Liabilities or the Business, and Seller shall
furnish promptly to Purchaser such information concerning the Conveyed Assets,
the Assumed Liabilities or the Business as Purchaser may reasonably request;
<U>provided</U>, <U>however</U>, that any such access shall be conducted in
such a manner as not to materially interfere with the operation of Seller&#146;s
business. Notwithstanding the foregoing, (i)&nbsp;Seller need not disclose to
Purchaser any information that would violate applicable Law, result in a breach
of attorney-client privilege or violate any confidentiality agreement or
similar agreement or arrangement to which Seller is a party and (ii)&nbsp;Seller may
redact such portions of its books and records that do not directly relate to the Conveyed Assets, the Assumed
Liabilities or the Business.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser will, and will cause its representatives to, hold any such
information obtained pursuant to Section&nbsp;5.2(a) in confidence, except to the
extent any such information (i)&nbsp;is or becomes publicly available other than as
a result of a breach of this Section&nbsp;5.2(b), (ii)&nbsp;is or becomes available to
Purchaser on a non-confidential basis from a source other than Seller, provided
that such source is not known to Purchaser to be bound by a confidentiality
agreement with Seller or otherwise prohibited from transmitting the information
to Purchaser by a contractual, legal or fiduciary obligation, (iii)&nbsp;was in the
possession of Purchaser prior to its being furnished to it by Seller, (iv)&nbsp;has
been or is independently developed by Purchaser or (v)&nbsp;is required to be
disclosed by Law or Governmental Entity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing, for so long as such information is retained by
Purchaser (which shall be for no less than the period of time that Purchaser
customarily would retain similar information), Purchaser shall permit Seller
and its authorized representatives to have reasonable access during normal
business hours, upon reasonable prior notice to Purchaser, to the books,
records and personnel relating to the Conveyed Assets, the Assumed Liabilities
or the conduct of the Business by Seller, to the extent that such access may be
reasonably required (i)&nbsp;in connection with the preparation of Seller&#146;s
accounting records or with any audits, (ii)&nbsp;in connection with the preparation
of any Tax Returns or with any Tax audits, (iii)&nbsp;in connection with any suit,
claim, action, proceeding or investigation relating to Seller&#146;s conduct of the
Business or (iv)&nbsp;in connection with any regulatory filing or matter;
<U>provided</U>, that such access shall be conducted in such a manner as not to
materially interfere with Purchaser&#146;s business, and <U>provided</U>,
<U>further</U>, that Seller shall reimburse Purchaser promptly for all
reasonable out-of-pocket costs and expenses incurred by Purchaser in connection
with any such request. Notwithstanding the foregoing, (i)&nbsp;Purchaser need not
disclose to Seller any information
</FONT>
<P align="center"><FONT size="2">17</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">which would violate applicable Law, result
in a breach of attorney-client privilege or violate any confidentiality
agreement or similar agreement or arrangement to which Purchaser is a party and
(ii)&nbsp;Purchaser may redact such portions of its books and records that do not
directly relate to the Conveyed Assets, the Assumed Liabilities or the
Business. Purchaser may, as it deems reasonably necessary or advisable,
designate any competitively sensitive information provided to Seller under this
Section&nbsp;5.2(c) as available to &#147;outside counsel and retained experts only.&#148;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall, and shall instruct its employees to, at Seller&#146;s
request, cooperate with Seller as may be reasonably required in connection with
the investigation and defense of any suit, claim, action, proceeding or
investigation relating to the Business that is brought against Seller or any of
its Affiliates at any time after the Closing; <U>provided</U>, <U>however</U>,
that Seller shall reimburse Purchaser promptly for all reasonable out-of-pocket
costs and expenses incurred by Purchaser in connection with any such request.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall, and shall instruct its employees to, at Purchaser&#146;s
request, cooperate with Purchaser as may be reasonably required in connection with the investigation and defense of any suit, claim, action,
proceeding or investigation relating to the Business that is brought against
Purchaser or any of its Affiliates at any time after the Closing;
<U>provided</U>, <U>however</U>, that Purchaser shall reimburse Seller promptly
for all reasonable out-of-pocket costs and expenses incurred by Seller in
connection with any such request.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Appropriate Action; Consents; Filings</U>. (a)&nbsp;Subject to
Section&nbsp;5.3(c) hereof, Seller and Purchaser shall use their reasonable best
efforts to take, or cause to be taken, all actions and do, or cause to be done,
all things necessary, proper or advisable under applicable Law or otherwise to
consummate and make effective the transactions contemplated by this Agreement
as promptly as practicable, including to: (i)&nbsp;obtain from Governmental
Entities any consents, licenses, permits, waivers, approvals, authorizations or
orders required (A)&nbsp;to be obtained by Seller or Purchaser or any of their
respective Affiliates to consummate the transactions contemplated by this
Agreement or (B)&nbsp;to avoid any action or proceeding by any Governmental Entity
in connection with the authorization, execution and delivery of this Agreement
and to permit the consummation of the transactions contemplated hereby to occur
as promptly as practicable; (ii)&nbsp;make all necessary filings, and thereafter
make any other required submissions, with respect to this Agreement required
under the FDCA or any other applicable Law; (iii)&nbsp;obtain all necessary
consents, waivers, approvals and authorizations of third parties; and (iv)
defend any suits or proceedings, whether judicial or administrative,
challenging this Agreement or the consummation of the transactions contemplated
hereby. Seller and Purchaser shall cooperate with each other in connection
with the making of all filings referenced in the preceding sentence, including
providing copies of all such documents to the non-filing party and its advisors
prior to filing and, if requested, to accept all reasonable additions,
deletions or changes suggested in connection therewith. Seller and Purchaser
shall have the right to review in advance, and, to the extent practicable and
reasonable, each shall consult the other on, all the information relating to
Seller or Purchaser, as the case may be, that appears in any filing made with,
or written materials submitted to, any third party
</FONT>
<P align="center"><FONT size="2">18</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">and/or any Governmental
Entity in connection with the transactions contemplated by this Agreement.
Seller and Purchaser may, as each deems reasonably necessary or advisable,
designate any competitively sensitive information provided to the other under
this Section&nbsp;5.3(a) as available to &#147;outside counsel and retained experts
only.&#148; Such information shall be given only to outside counsel of the
recipient. In addition, Purchaser and Seller may redact any information from
such documents shared with the other party or its counsel that is not pertinent
to the subject matter of the filing or submission.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without limiting Section&nbsp;5.3(a), but subject to Section&nbsp;5.3(c),
Purchaser and Seller shall use their respective reasonable best efforts to
obtain, or to cause to be obtained, any consent, substitution, approval,
authorization or amendment from, and to provide any notice to, applicable
Governmental Entities and third parties required to assign or transfer any
Conveyed Asset to Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary (including
paragraphs (a)&nbsp;and (b)&nbsp;of this Section&nbsp;5.3), neither Purchaser nor any of its Affiliates shall be required to commit to any divestitures, licenses or
hold separate or similar arrangements with respect to its assets or conduct of
business arrangements, whether as a condition to obtaining any approval from a
Governmental Entity or any other Person or for any other reason.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances</U>. From time to time following the
Closing, Seller and Purchaser shall, and shall cause their respective
Affiliates to, execute, acknowledge and deliver all such further conveyances,
notices and other instruments, and take such further actions, as may be
necessary or appropriate to assure fully to Purchaser, its successors and
assigns all of the properties, rights, titles, interests, estates, remedies,
powers and privileges intended to be conveyed to Purchaser under this Agreement
and to otherwise make effective the transactions contemplated hereby. Such
actions shall include, without limitation, causing the release of any Liens on
the Conveyed Assets, including any Liens in connection with the Master Loan and
Security Agreement No.&nbsp;7711, dated November&nbsp;19, 1999, between Oxford Venture
Finance, LLC and Seller, and the filing of UCC-3 Termination Statements to
reflect the release of such Liens.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>. (a)&nbsp;Seller shall pay any and all
Transaction Taxes imposed in connection with the transfer of the Conveyed
Assets, the assumption of the Assumed Liabilities and the execution, delivery
or performance of any of the Related Instruments, and shall file such
applications and documents as shall permit any such Transaction Taxes to be
assessed and paid on or prior to the Closing Date in accordance with any
available pre-sale filing procedures.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall pay all Taxes with respect to the Conveyed Assets,
regardless of when due and payable, (i)&nbsp;with respect to all taxable periods
ending on or prior to the Closing Date and (ii)&nbsp;with respect to all taxable
periods beginning before the Closing Date and ending after the Closing Date,
but only with respect to the portion of such periods up to and including the
Closing Date. After the Closing Date, all refunds of Taxes paid by Seller that
are attributable to any such periods shall be for the account of Seller.
</FONT>
<P align="center"><FONT size="2">19</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in Section&nbsp;5.5(a), Purchaser shall pay
all Taxes with respect to the Conveyed Assets, regardless of when due and
payable, (i)&nbsp;with respect to all taxable periods beginning after the Closing
Date and (ii)&nbsp;with respect to all taxable periods beginning before the Closing
Date and ending after the Closing Date, but only with respect to the portion of
such periods commencing after the Closing Date. All refunds of Taxes paid by
Purchaser that are attributable to any such periods shall be for the account of
Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Publicity</U>. Except as otherwise required by applicable
Law or applicable stock exchange or Nasdaq National Market System requirements,
neither Purchaser nor Seller shall, and each of them shall cause their respective Affiliates,
representatives and agents not to, issue or cause the publication of any press
release or public announcement with respect to the transactions contemplated by
this Agreement without the express prior approval of the other party, which
approval shall not be unreasonably withheld or delayed.; <U>provided</U>,
<U>however</U>, that each of Seller and Purchaser may make any public statement
in response to questions by the press, analysts, investors or those attending
industry conferences or financial analyst calls, or issue press releases, so
long as any such public statement or press release is not inconsistent with
prior public disclosures, press releases or public statements approved by the
other party in accordance with this Section&nbsp;5.6 and which do not reveal
non-public information about the other party.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Provisions Relating to the Transfer</U>. Except in
respect of Nonassignable Assets (which are the subject of Section&nbsp;2.5 hereof),
in the event that record or beneficial ownership or possession of any Conveyed
Asset has not been transferred to Purchaser on the Closing Date, Seller and
Purchaser shall cooperate and shall use their reasonable best efforts to
transfer, or cause to be transferred, as promptly as practicable, from Seller
to Purchaser such Conveyed Asset, and pending such transfer to Purchaser,
Seller shall hold such Conveyed Asset and provide to Purchaser all of the
benefits and liabilities associated with the ownership and operation of such
Conveyed Asset and, accordingly, Seller shall cause such Conveyed Asset to be
operated or retained as may reasonably be instructed by Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Supplemental Disclosure</U>. Each party will promptly
notify the other party in writing if it is in, or becomes aware of any fact or
condition that causes or constitutes a, breach of any of its representations or
warranties as of the date of this Agreement, or if it becomes aware of the
existence or occurrence after the date of this Agreement of any fact or
condition that would (except as expressly contemplated by this Agreement) cause
or constitute a breach of any of its representations or warranties had any such
representation or warranty been made as of the time of the existence,
occurrence or discovery of such fact or condition. The delivery of any notice
pursuant to this Section&nbsp;5.8 shall not limit or otherwise affect the remedies
available hereunder to a party receiving such notice.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closing Documents</U>. At or prior to the Closing, (i)
Seller shall execute and deliver, or cause to be executed and delivered, to
Purchaser the documents and instruments described in Section&nbsp;2.4(b) and (ii)
Purchaser shall execute
</FONT>
<P align="center"><FONT size="2">20</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><FONT size="2">and deliver, or cause to be executed and delivered, to
Seller the documents and instruments described in Section&nbsp;2.4(c).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patent Prosecution</U>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall render reasonable assistance to Purchaser in the Prosecution
of the Conveyed Intellectual Property whenever requested to do so, at
Purchaser&#146;s expense, including without limitation to cooperate, and to require
each past or present employee, consultant, representative, contractor, agent or other individual under
the custody or control of Seller (including without limitation any such
individual that is, or is identified as, an inventor of any of the Conveyed
Intellectual Property) to cooperate, with Purchaser, its attorneys, agents,
successors and assigns, to Prosecute, assert, enforce and defend, and to
otherwise protect any and all of the Conveyed Intellectual Property and
Purchaser&#146;s rights and title therein, including, without limitation, to (a)
execute such documents, sign all lawful papers, and make all rightful oaths as
Purchaser deems reasonably necessary or appropriate in connection with same;
(b)&nbsp;communicate any facts known or reasonably available respecting any of the
Conveyed Intellectual Property; and (c)&nbsp;provide all documents, samples and
other tangible materials necessary or useful testimony to Prosecute, assert,
enforce and/or defend any of the Conveyed Intellectual Property.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Competition</U>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For a period of fifteen (15)&nbsp;years after the Closing Date, neither
Seller nor any of its Subsidiaries (each, a &#147;<U>Restricted Party</U>&#148; and,
collectively, the &#147;<U>Restricted Parties</U>&#148;) shall, directly or indirectly,
anywhere in the world, engage in the Business as currently conducted
(&#147;<U>Competitive Activity</U>&#148;); <U>provided</U>, <U>however</U>, that it shall
not be a violation of this Section&nbsp;5.10(a) for a Restricted Party to (i)&nbsp;own
any debt securities or other debt obligations (other than convertible debt) of
any Person, (ii)&nbsp;invest in, own an interest in or acquire all or a majority of
the stock or assets of any Person that is not &#147;significantly engaged in a
Competitive Activity&#148; (as defined below) or (iii)&nbsp;invest in securities
representing less than five percent (5%) of the outstanding capital stock of
any Person, the securities of which are publicly traded or listed on any
securities exchange or automated quotation system. For purposes of this
Section&nbsp;5.10(a), &#147;<U>significantly engaged in a Competitive Activity</U>&#148; shall
mean that at least 10% of the consolidated net revenue derived during the last
complete fiscal year of the acquired Person is derived from a Competitive
Activity.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree that the covenants set forth in this Section
5.10 shall be enforced to the fullest extent permissible under applicable Law.
If all or any part of this Section&nbsp;5.10 is held invalid, illegal or incapable
of being enforced by any Law or public policy, all other terms and provisions
of this Agreement shall nevertheless remain in full force and effect. Seller
agrees that in the event of a breach or threatened breach by it or any of its
Subsidiaries of the provisions of this Section&nbsp;5.10, money damages would not be
an adequate remedy and that Purchaser shall be entitled to seek temporary,
preliminary or permanent injunctive relief without the necessity of posting a
bond. If any part of this Section&nbsp;5.10 is held to be excessively broad as to
</FONT>
<P align="center"><FONT size="2">21</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">duration, scope, activity or subject, such part will be construed by limiting
and reducing it so as to be enforceable to the maximum extent compatible with
applicable Law.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality</U>.
</FONT>
<P><FONT size="2">For purposes of this Agreement, all information pertaining to the Conveyed
Assets, including without limitation the Conveyed Intellectual Property, the
Prosecution, assertion, enforcement or defense of any of same, and the
Regulatory Filings, shall be treated by Seller as the &#147;Confidential
Information&#148; of Purchaser.
</FONT>
<P><FONT size="2"><U>Restrictions on Disclosure and Use</U>. With regard to Confidential
Information, for a period beginning on the Closing Date and continuing for a
period of ten (10)&nbsp;years, Seller agrees:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not to use the Confidential Information except for the sole purpose of
performing under the terms of this Agreement;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to use its best efforts to safeguard Confidential Information against
disclosure to others; and
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not to disclose Confidential Information to others (except to its
employees, agents or consultants who are bound by a like obligation of
confidentiality) without the express prior written permission of Purchaser,
</FONT>
<P><FONT size="2">except that Seller shall not be prevented from using or disclosing any of the
Confidential Information which:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="3%"></TD>
        <TD width="97%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is now, or becomes in the future, public knowledge other
than through any act or omission by or on behalf of Seller or any
past or present employee, agent, contractor or consultant thereof;</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is lawfully obtained by Seller from a source independent
of Purchaser, provided that such source is not known to Seller to
be bound by a confidentiality agreement with Purchaser or
otherwise prohibited from transmitting the information to Seller
by a contractual, legal or fiduciary obligation; or</FONT></TD>
</TR>

<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is required by Law to be disclosed, only to the extent
so required and provided that Seller notifies Purchaser
sufficiently prior to the deadline for such disclosure to permit
Purchaser to seek, at Seller&#146;s expense, a protective order or
confidential treatment or otherwise limit the extent of such
disclosure, and cooperates with Purchaser in obtaining same.</FONT></TD>
</TR>

</TABLE>
<P align="center"><FONT size="2">22</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>





<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights to Certain Technologies of Seller</U>.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At any time during the period commencing on the Closing Date and ending on
the date that is one year after the Closing Date, Purchaser may notify Seller
in writing of Purchaser&#146;s election (the &#147;Election&#148;) to enter into a license
agreement with Seller for Purchaser to develop one of the following
pre-clinical products (each, a &#147;Pre-Clinical Product&#148;):
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hepatocyte growth factor (HGF)&nbsp;proteins and fragments thereof;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prostate specific antigen (PSA)&nbsp;and fragments thereof; and
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tissue factor pathway inhibitor protein (TFPI).
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following Seller&#146;s receipt of Purchaser&#146;s Election, Purchaser and Seller
shall negotiate in good faith the terms of such license agreement for a period
of 60&nbsp;days, consistent with commercially reasonable terms in the biotechnology
industry, provided that such license agreement shall provide for no up-front
license fee and royalty payments of no more than 5% of revenues derived from
such Pre-Clinical Product. Seller may not enter into any license agreement
with respect to such Pre-Clinical Product with a third party unless Purchaser
and Seller do not reach agreement by the end of such 60-day period, after which
time Seller may only enter into a license agreement with respect to such
Pre-Clinical Product on terms and conditions that are no more favorable to such
third party than the most favorable terms and conditions proposed by Seller to
Purchaser at any time during such 60-day period.
</FONT>
<P align="center"><FONT size="2">ARTICLE VI
</FONT>
<P align="center"><FONT size="2">CONDITIONS
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Each Party&#146;s Obligations</U>. The respective
obligations of each party to effect the transactions contemplated by this
Agreement shall be subject to the satisfaction at or prior to the Closing of
the following condition: There shall not be in effect any Law of any
Governmental Entity that makes illegal, enjoins or prevents the consummation of
the transactions contemplated by this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Obligations of Purchaser</U>. The obligation
of Purchaser to effect the transactions contemplated by this Agreement shall be
further subject to the satisfaction at or prior to the Closing of the following
conditions, any or all of which may be waived, in whole or in part, by
Purchaser:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The representations and warranties of Seller contained in Article&nbsp;III
of this Agreement that are qualified by reference to materiality or Material
Adverse Effect shall be true and correct in all respects, and the
representations and warranties of Seller contained in Article&nbsp;III of this Agreement that are
not so qualified shall be true and correct in all material respects, at and as
of the Closing Date as if made at and as of such time (except to the extent
expressly made as of an earlier date, in which case as of such earlier date);
<P align="center"><FONT size="2">23</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall have performed and complied with in all material respects
all agreements and covenants required to be performed or complied with by
Seller under this Agreement at or prior to the Closing;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall have received from Seller a certificate, dated the
Closing Date, duly executed by an officer of Seller, to the effect of Section
6.2(a) and Section&nbsp;6.2(b) above; and
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall have delivered or caused to be delivered to Purchaser
each of the documents specified in Section&nbsp;2.4(b) hereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Obligations of Seller</U>. The obligation of
Seller to effect the transactions contemplated by this Agreement shall be
further subject to the satisfaction at or prior to the Closing of the following
conditions, any or all of which may be waived, in whole or in part, by Seller:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The representations and warranties of Purchaser contained in Article
IV of this Agreement that are qualified by reference to materiality or Material
Adverse Effect shall be true and correct in all respects, and the
representations and warranties of Purchaser contained in Article&nbsp;IV of this
Agreement that are not so qualified shall be true and correct in all material
respects, at and as of the Closing Date as if made at and as of such time
(except to the extent expressly made as of an earlier date, in which case as of
such earlier date);
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall have performed and complied with in all material
respects all agreements and covenants required to be performed or complied with
by Purchaser under this Agreement at or prior to the Closing;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall have received from Purchaser a certificate dated the
Closing Date, duly executed by an officer of Purchaser, to the effect of
Section&nbsp;6.3(a) and Section&nbsp;6.3(b) above; and
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall have delivered or caused to be delivered to Seller
each of the documents specified in Section&nbsp;2.4(c) hereof.
</FONT>
<P align="center"><FONT size="2">ARTICLE VII
</FONT>
<P align="center"><FONT size="2">TERMINATION AND AMENDMENT
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated at any
time prior to the Closing by:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mutual written consent of Seller and Purchaser;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;either Seller or Purchaser, if the Closing shall not have occurred on
or before December&nbsp;31, 2002 (the &#147;<U>Outside Date</U>&#148;); <U>provided</U>,
<U>however</U>, that the right to terminate this Agreement under this Section
7.1(b) shall not be available to a
</FONT>
<P align="center"><FONT size="2">24</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">party whose failure to perform its
obligations under this Agreement has been the cause of, or resulted in, the
failure of the Closing to occur on or before the Outside Date;
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;either Seller or Purchaser, if a competent Governmental Entity shall
have issued a ruling, decree, order or injunction or taken any other action
which, in any such case, permanently restrains, enjoins or prohibits the
consummation of the transactions contemplated hereby and such ruling, decree,
order or injunction or other action shall have become final and non-appealable;
<U>provided</U>, <U>however</U>, that in the event that such ruling, decree,
order or injunction or other action has been entered, the party seeking to
terminate this Agreement pursuant to this Section&nbsp;7.1(c) shall have used its
reasonable best efforts to remove such ruling, decree, order, injunction or
other action; or
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;either Seller or Purchaser (provided that the terminating party is not
then in material breach of any representation, warranty, covenant or other
agreement contained herein), if there shall have been a breach of any of the
representations, warranties, covenants or agreements set forth in this
Agreement on the part of the other party such that any of the conditions set
forth in Article&nbsp;VI would not be satisfied, such breach has not been waived by
the terminating party, and such breach has not been cured within 30&nbsp;days
following the terminating party&#146;s written notice of such breach to the other
party.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Termination</U>. In the event of the termination
of this Agreement pursuant to Section&nbsp;7.1 hereof, this Agreement shall
forthwith become null and void and have no effect, without any liability on the
part of either party hereto or its Affiliates, directors, officers or
stockholders, other than the provisions of Article&nbsp;IX and Sections&nbsp;5.2(b) and
7.2 hereof; <U>provided</U>, <U>however</U>, that nothing contained in this
Section&nbsp;7.2 shall relieve either party to this Agreement from liability to the
other party for any breach of this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>. This Agreement may be amended or modified
at any time by Seller and Purchaser, but only by an instrument in writing
signed by or on behalf of each of Seller and Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Extension; Waiver</U>. At any time prior to the Closing,
either party hereto may (i)&nbsp;extend the time for the performance of any of the
obligations or acts of the other party, (ii)&nbsp;waive any inaccuracies in the
representations and warranties of the other party contained herein or in any
document delivered pursuant hereto, (iii)&nbsp;waive compliance with any of the
agreements of the other party contained herein or (iv)&nbsp;waive any condition to
its obligations hereunder. Any agreement on the part of a party hereto to any
such extension or waiver shall be valid only if set forth in a written
instrument signed by or on behalf of such party. Except as otherwise expressly
provided herein, no failure to exercise, delay in exercising, or single or
partial exercise of any right, power or remedy by any party, and no course of
dealing between the parties, shall constitute a waiver of any such right, power
or remedy.
</FONT>
<P align="center"><FONT size="2">25</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2">ARTICLE VIII
</FONT>
<P align="center"><FONT size="2">SURVIVAL; INDEMNIFICATION
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival Period</U>. The representations and warranties of
the parties contained in Articles III and IV hereof shall survive the Closing
until the second anniversary of the Closing Date; <U>provided</U>,
<U>however</U>, that the representations and warranties of Seller contained in
Section&nbsp;3.13 hereof shall survive the Closing until the date that is 90&nbsp;days
after the expiration of the applicable statute of limitations and the
representations and warranties of Seller contained in Sections&nbsp;3.1, 3.2 and
3.10 hereof and of Purchaser contained in Sections&nbsp;4.1, 4.2 and 4.5 hereof
shall survive the Closing indefinitely. The period of time a representation or
warranty survives the Closing pursuant to the preceding sentence shall be the
&#147;<U>Survival Period</U>&#148; with respect to such representation or warranty. The
covenants and agreements of the parties hereto contained herein shall survive
in accordance with their respective terms. In the event notice of any claim for
indemnification under Sections&nbsp;8.2(a)(i) or 8.2(b)(i) hereof shall have been
given within the applicable Survival Period and such claim has not been finally
resolved by the expiration of such Survival Period, the representations and
warranties that are the subject of such claim shall survive with respect to
such claim until such claim is finally resolved.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>. Subject to the terms and conditions
set forth in this Article&nbsp;VIII, from and after the Closing:
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall defend, indemnify and hold harmless Purchaser and its
Affiliates and their respective directors, officers, equity holders, employees,
agents, legal counsel, independent accountants and representatives and their
respective heirs, successors and assigns (collectively, the &#147;<U>Purchaser
Indemnified Parties</U>&#148;) from and against any and all Losses that are directly
or indirectly imposed on, suffered or incurred by any Purchaser Indemnified
Party arising out of or relating to (i)&nbsp;any breach of, or inaccuracy in, any
representation or warranty of Seller in this Agreement or any of the Related
Instruments, (ii)&nbsp;any failure to perform, or breach of, any covenant or
agreement of Seller set forth in this Agreement or any of the Related
Instruments, (iii)&nbsp;any of the Excluded Liabilities or (iv)&nbsp;the conduct of the
Business prior to the Closing or in connection with the performance by Seller
of this Agreement. &#147;<U>Losses</U>&#148; shall mean any and all liabilities,
obligations, losses, assessments, judgments, fines, damages, deficiencies,
demands, claims, actions, causes of action, costs and expenses (including, without limitation, interest, penalties, court costs and reasonable
attorneys&#146; fees and expenses and any amounts paid in investigation, defense or
settlement of any of the foregoing), of any kind, manner or nature whatsoever,
whether or not arising out of third-party claims.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall defend, indemnify and hold harmless Seller and its
Affiliates and their respective directors, officers, equity holders, employees,
agents, legal counsel, independent accountants and representatives and their
respective heirs, successors and assigns (collectively, the &#147;<U>Seller
Indemnified Parties</U>&#148;) from and against any and all Losses that are directly
or indirectly imposed on, suffered or incurred
</FONT>
<P align="center"><FONT size="2">26</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">by any Seller Indemnified Party
arising out of or relating to (i)&nbsp;any breach of, or inaccuracy in, any
representation or warranty of Purchaser in this Agreement or any of the Related
Instruments, (ii)&nbsp;any failure to perform, or breach of, any covenant or
agreement of Purchaser set forth in this Agreement or any of the Related
Instruments, (iii)&nbsp;any of the Assumed Liabilities or (iv)&nbsp;the conduct of the
Business after the Closing.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification Procedures</U>. (a)&nbsp;All claims for
indemnification by any party entitled to indemnification under this Article
VIII (an &#147;<U>Indemnified Party</U>&#148;) with respect to a third-party claim shall
be asserted and resolved as set forth in this Section&nbsp;8.3. In the event that
any claim or demand by a third party for which a party hereto (the
&#147;<U>Indemnifying Party</U>&#148;) may be required to indemnify any Indemnified Party
hereunder (a &#147;<U>Claim</U>&#148;) is asserted against or sought to be collected from
any such Indemnified Party by a third party, such Indemnified Party shall as
promptly as practicable notify the Indemnifying Party in writing of such Claim,
and such notice shall specify (to the extent known) in reasonable detail the
amount of such Claim and any relevant facts and circumstances relating thereto
(the &#147;<U>Claim Notice</U>&#148;); <U>provided</U>, <U>however</U>, that any failure
to give such prompt notice or to provide any such facts and circumstances shall
not constitute a waiver of any rights of the Indemnified Party, except to the
extent that the rights of the Indemnifying Party are materially prejudiced
thereby.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indemnifying Party shall have 15&nbsp;days from delivery of the Claim
Notice to notify the Indemnified Party whether or not the Indemnifying Party
elects to defend the Indemnified Party against such Claim. In the event that
the Indemnifying Party notifies the Indemnified Party that it elects to defend
the Indemnified Party against such Claim, the Indemnifying Party shall have the
right to defend the Indemnified Party by appropriate proceedings and shall
control such defense at the Indemnifying Party&#146;s expense. After notice to the
Indemnified Party of the Indemnifying Party&#146;s election to assume the defense of
such Claim, the Indemnifying Party shall not be liable to the Indemnified Party
for any legal expenses subsequently incurred by the Indemnified Party in
connection with the defense thereof unless the Indemnifying Party fails to
diligently pursue the defense of such Claim; <U>provided</U> that the
Indemnified Party shall have the right to employ counsel to represent it if the
Indemnified Party has been advised by counsel that either (x)&nbsp;such Claim
involves remedies which, in the Indemnified Party&#146;s reasonable judgment, could
have a material adverse effect on such Indemnified Party, (y)&nbsp;the Indemnified
Party may have available to it one or more defenses or counterclaims which are inconsistent with or additional to
those available to the Indemnifying Party or (z)&nbsp;the use of counsel chosen by
the Indemnifying Party would present such counsel with a conflict of interest,
and in any such event the fees and expenses of such separate counsel shall be
paid by the Indemnifying Party; provided, however, that the Indemnifying Party
shall not be responsible for the fees and expenses of more than one counsel for
all Indemnified Parties with respect to such Claim. If the Indemnifying Party
elects not to defend the Indemnified Party against such Claim, then the
Indemnified Party shall defend such Claim by appropriate proceedings and shall
control such defense, at the expense of the Indemnifying Party.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties shall render to each other such assistance as may
reasonably be requested, at the expense of the Indemnifying Party, in order to
insure
</FONT>
<P align="center"><FONT size="2">27</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">the proper and adequate defense of any such Claim, including making
employees available on a mutually convenient basis to provide additional
information and explanation of any relevant materials or to testify at any
proceedings relating to such Claim and giving the other party reasonable access
to any books, records and other documents and information relating to the
defense of such Claim.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indemnifying Party will not consent to the entry of any judgment
or enter into any settlement with respect to a Claim without the prior written
consent of the Indemnified Party, unless the judgment or settlement (x)
involves only the payment of money damages and (y)&nbsp;includes as an unconditional
term thereof the giving by the claimant or plaintiff to the Indemnified Party
of an unconditional release from all liability in respect of the Claim. The
Indemnified Party will not consent to the entry of any judgment or enter into
any settlement with respect to a Claim without the prior written consent of the
Indemnifying Party, which shall not be unreasonably withheld or delayed.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Qualifications on Liability</U>. (a)&nbsp;In no event shall
Seller be liable for indemnification pursuant to Section&nbsp;8.2(a)(i) unless and
until the aggregate amount of all Losses which are incurred or suffered by the
Purchaser Indemnified Parties thereunder exceeds $60,000, in which case the
Purchaser Indemnified Parties shall only be entitled to indemnification for
such Losses in excess of such amount; <U>provided</U>, <U>however</U>, that
Seller shall not be required to make payments for indemnification pursuant to
Section&nbsp;8.2(a)(i) in an aggregate amount in excess of the Purchase Price.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In no event shall Purchaser be liable for indemnification pursuant to
Section&nbsp;8.2(b)(i) unless and until the aggregate amount of all Losses which are
incurred or suffered by the Seller Indemnified Parties thereunder exceeds
$60,000, in which case the Seller Indemnified Parties shall only be entitled to
indemnification for such Losses in excess of such amount; <U>provided</U>,
<U>however</U>, that Purchaser shall not be required to make payments for
indemnification pursuant to Section&nbsp;8.2(b)(i) in an aggregate amount in excess
of the Purchase Price.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although a representation, warranty, covenant or agreement of either
party hereto may not be deemed breached or inaccurate unless or until a certain
standard as to &#147;material,&#148; &#147;materiality&#148; or &#147;Material Adverse Effect&#148; has been
met, for purposes of calculating Losses in connection with this Article&nbsp;VIII,
once such standard has been met, the Indemnified Party shall be entitled to
indemnification for all Losses arising out of or relating to such breach or
inaccuracy of any such representation, warranty, covenant or agreement without
giving effect to any such standard.
</FONT>
<P align="center"><FONT size="2">ARTICLE IX
</FONT>
<P align="center"><FONT size="2">MISCELLANEOUS
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. Any notices or other communications required
or permitted under, or otherwise in connection with, this Agreement shall be in
writing and shall be deemed to have been duly given (w)&nbsp;when delivered in
person, (x)&nbsp;upon confirmation of receipt when transmitted by facsimile
transmission, (y)&nbsp;on receipt after dispatch by registered or certified mail,
postage prepaid, or (z)&nbsp;on the next Business Day
</FONT>
<P align="center"><FONT size="2">28</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">if transmitted by national
overnight courier, addressed in each case as follows (or to such other address
which has been delivered in accordance with this Section&nbsp;9.1):
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="55%">
<TR valign="bottom">
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="86%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">(a)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
if to Purchaser, to:<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Celgene Corporation</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
7 Powder Horn Drive</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Warren, New Jersey 07059</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Telephone: (732)&nbsp;271-1001</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Facsimile: (732)&nbsp;805-3931</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Attention: Robert J. Hugin<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
with a copy to:<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Proskauer Rose LLP</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
1585 Broadway</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
New York, New York 10036</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Telephone: (212)&nbsp;969-3000</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Facsimile: (212)&nbsp;969-2900</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Attention: Robert A. Cantone, Esq.<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">(b)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
if to Seller, to:<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
EntreMed, Inc.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
9640 Medical Center Drive</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Rockville, Maryland 20850</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Telephone: (240)&nbsp;864-2600</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Facsimile: (240)&nbsp;864-2601</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Attention: President<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
with a copy to:<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Arnold &#038; Porter</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
555 Twelfth Street, NW</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Washington, DC 20004</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Telephone: (202)&nbsp;942-5000</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Facsimile: (202)&nbsp;942-5999</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Attention: Richard E. Baltz, Esq.</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Descriptive Headings</U>. The descriptive headings herein
are inserted for convenience only and are not intended to be part of or to
affect the meaning or interpretation of this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts; Facsimile Signatures</U>. This Agreement may
be executed in counterparts, each of which shall be deemed an original, but
both of which together shall constitute one and the same agreement. In the
event that any
</FONT>
<P align="center"><FONT size="2">29</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">signature is delivered by facsimile transmission, such signature
shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) the same with the same force and effect as
if such facsimile signature page were an original thereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. This Agreement, the exhibits and
schedules hereto, the Seller Disclosure Letter and the Related Instruments
constitute the entire agreement of the parties hereto, and supersede all prior
agreements and understandings, both written and oral, between the parties with
respect to the subject matter hereof, including, without limitation, the
Confidentiality Agreement, dated December&nbsp;16, 2002, between Seller and
Purchaser.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees and Expenses</U>. Regardless of whether or not the
transactions contemplated by this Agreement are consummated, each party shall
bear its own fees and expenses incurred in connection with the negotiation,
execution, delivery and performance of this Agreement and the Related
Instruments, except as otherwise expressly provided herein.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Agreement shall be governed and
construed in accordance with the Laws of the State of New York, without regard
to any applicable principles of conflicts of law. Each of the parties hereto
hereby irrevocably and unconditionally consents to submit to the exclusive
jurisdiction of the courts of the State of New York located in New York County and of the United States District Court for the Southern
District of New York, as well as any courts of appeal therefrom, for any
litigation arising out of or relating to this Agreement, any of the Related
Instruments or any of the transactions contemplated hereby or thereby (and
agrees not to commence any litigation relating thereto except in such courts).
Each of the parties hereto hereby irrevocably and unconditionally waives any
objection to the laying of venue of any litigation arising out of or relating
to this Agreement, any of the Related Instruments or any of the transactions
contemplated hereby or thereby in the courts of the State of New York located
in New York County and of the United States District Court for the Southern
District of New York, as well as any courts of appeal therefrom, and hereby
further irrevocably and unconditionally waives and agrees not to plead or claim
in any such court that any such litigation brought in any such court has been
brought in an inconvenient forum. The parties agree that a final judgment in
any such litigation shall be conclusive and may be enforced in other
jurisdictions by suits on the judgment or in any other manner provided by Law.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>WAIVER OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO
HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY
OF THE RELATED INSTRUMENTS OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR
THEREBY.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignment</U>. Neither this Agreement nor any of the
rights, interests or obligations hereunder shall be transferred, assigned or
delegated by
</FONT>
<P align="center"><FONT size="2">30</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P><FONT size="2">either of the parties hereto, in whole or in part, without the
prior written consent of the other party hereto, and any attempt to make any
such transfer, assignment or delegation without such consent shall be null and
void.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties in Interest</U>. This Agreement shall be binding
upon and inure solely to the benefit of each party hereto and its successors
and permitted assigns, and, except as expressly provided herein, nothing in
this Agreement, express or implied, is intended to or shall confer upon any
other Person any rights, interests, benefits or remedies of any nature
whatsoever under or by reason of this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;9.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretation</U>. In the event of an ambiguity or
question of intent or interpretation, this Agreement shall be construed as if
drafted jointly by the parties and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. In the event that any one or more of the provisions contained herein,
or the application thereof in any circumstance, is held invalid, illegal or
unenforceable in any respect for any reason, the parties shall negotiate in
good faith with a view to the substitution therefor of a suitable and equitable
solution in order to carry out, so far as may be valid and enforceable, the
intent and purpose of such invalid provision; <U>provided</U>, <U>however</U>,
that the validity, legality and enforceability of any such provision in every
other respect and of the remaining provisions contained herein shall not be in
any way impaired thereby, it being intended that all of the rights and
privileges of the parties hereto shall be enforceable to the fullest extent
permitted by Law.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments</U>. Unless otherwise provided herein, all
payments required to be made pursuant to this Agreement shall be made in U.S.
dollars in the form of cash or by wire transfer of immediately available funds
to an account designated by the party receiving such payment.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bulk Sales Laws</U>. Purchaser waives compliance by
Seller with any bulk sales or similar Laws applicable to the transactions
contemplated hereby.
</FONT>
<P align="center"><FONT size="2">31</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have executed this Asset Purchase
Agreement as of the date first written above.
</FONT>
<p align="right">
<TABLE cellspacing="0" border="0" cellpadding="0" width="50%">
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top" colspan="3"><FONT size="2">
CELGENE CORPORATION<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">By:</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>/s/ Neil Campbell</U></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Name: Neil Campbell</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Title: President &#038; COO<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD align="left" valign="top" colspan="3"><FONT size="2">
ENTREMED, INC.<p></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">By:</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<U>/s/ Robert J. Hugin</U></FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Name: Robert J. Hugin</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Title: Senior Vice President</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and CFO</FONT></TD>
</TR>
</TABLE>


<P align="center"><FONT size="2">32</FONT>




</BODY>
</HTML>

</TEXT>
</DOCUMENT>
